effective than CPAP. Positional device has been shown to be effective in some OSA patients and combination therapy might have synergistic effects.
groups on baseline mean age (55/58), BMI (27/27), ESS (9/9) and AHI (23/25). Table 1 shows outcomes of the two groups. Up to 89% of patients were woke up by the vibration 47% could not fall asleep again.
Conclusion:
Non CPAP combination therapy is feasible and effective in selected patients. Background and Aims: Excessive daytime sleepiness (EDS) is due to variable causes. Most patients, after a thorough clinical assessment, need a polysomnography to come to a correct diagnosis. This study is to explore the demographic profile of patients with EDS and any correlation with patients' profile.
Methods: This was a retrospective study looking at patients with EDS attending the Sleep Clinic in Hospital Taiping from April 2017 till February 2018. The data was retrieved from the outpatient notes and analyzed with SPSS version 21. Mann-Whitney U test was used to explore the association between the different parameters. Patients with an Epworth Sleepiness Score of more than 12 were included. All patients underwent a full night attended polysomnogram. Patients' age, ethnicity, comorbidities, BMI and sleep diagnosis were analyzed.
Results: 105 patient's data were analyzed, 61% were male and 39% were female. 61.9% were Malays, 12.4% were Chinese and 25.7% were Indians. Male patients had more severe OSA compared to females, which was statistically significant. 90.5% of patients were obese. 20% of patients had mild OSA, 15.2% had moderate OSA and 58.1% had severe OSA, 2.9% had primary central sleep apnoea, 1% had idiopathic hypersomnia, 1% had Cheyne Stoke Respiration and 2% had narcolepsy. 61.5% of male patients and 38.5% of female patients had OSA with obesity hypoventilation syndrome (OHS). All the patients with OHS had OSA. 59.1% of patients with severe OSA had hypertension and 85.7% of patients had both hypertension and diabetes mellitus. There was a statistically significant increase in the co-morbidities in patients with severe OSA compared to mild and moderate OSA. Methods: Medical records of patients with DMD, 5 to 18 y/o, referred to sleep lab for suspicious OSA from Jan. 2009 to Feb. 2018 were reviewed. OSA was defined as obstructive apnoea-hypopnea (AHI>1 /h) while hypoventilation was defined as %TST of PtcCO2>50 mmHg higher than 25%. Multivariable logistic regression was applied to identified clinical factors independently associated with OSA and %TST of PtcCO 2 >50 mmHg where the result was expressed as (odds ratio (OR) or coefficient; 95% confidence interval (CI)).
Results: Totally, 42 boys with DMD were enrolled with the man age of 9.65 years and body mass index (BMI) z score of −0.01. 64% had OSA and 10% had NH. OSA patients were older than non-OSA patients and two groups had similar pulmonary function parameters including forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1). NH patients were also older than non-NH patients. Age was the only factor independently associated with OSA (OR 1.637; 95% CI 1.03-12.597) and %TST of PtcCO2>50 mmHg (coefficient 3.537; 95%CI 0.994 to 6.080) after controlling BMI, FVC, and FEV1.
Conclusion: OSA was prevalent in DMD. Age was the independent factors for both of the OSA and %TST of PtcCO 2 >50 mmHg. Background and Aims: Neuromuscular compensation of the genioglossus muscle plays a critical role in maintaining upper airway patency in obstructive sleep apnoea. It has been proven that A7 pontine noradrenergic cell group projected to hypoglossal (XII) nucleus and can modulates XII nerve activity. But the precise mechanisms that A7 noradrenergic cell group could modulate GG activity are still unknown in rats. The aim of this work is to investigate role of A7 cell group, α2 adrenoceptor and G-protein-activated inwardly rectifying K+(GIRK) channels on A7 region in central regulation in rats.
Methods: Transcranial magnetic stimulation (TMS) (i.e., changes in latency and amplitude) and electromyogram (EMG) activity in genioglossus were analyzed before and after microinjection each agent in rats. Anti-DBH-saporin (noradrenergic neuron lesioning agent), RS-79948 (α2-adrenoceptor agonist), clonidine (α2-adrenoceptor antagonists), tertiapin-Q (GIRK channel blocker) and ML297 (GIRK channel activator) were microinjected into the A7 region, respectively.
Results: Lesions of noradrenergic A7 cell group evoked a significant inhibitory effect on GG activity. Microinjection of α-2-adrenoceptors agonist clonidine evoked a similar effect on GG activity, whereas the effect of clonidine was weakened in rats pre-injected with tertiapin-Q, GIRK channel blocker. In contrast, microinjection of α-2-adrenoceptors antagonist RS-79948 elicited a significant stimulatory effect on GG activity, whereas the effect of antagonist was weakened in rats pre-injected with ML297, GIRK channel activator.
The present results suggested that A7 cell group can modulate GG activity through GIRK channels by α2-adrenoceptor. GG activity can be inhibited by activating α2-adrenoceptor on A7 cell group.
Moreover, the effect of α2-adrenoceptor is functionally linked to GIRK channel regulation. This finding is an effective strategy for reversing upper airway hypotonia in subjects with obstructive sleep apnoea. titration studies are the gold standard method for prescribing PAP pressures for OSA patients but costly and time-consuming. Automatic PAP (APAP) titration is cost effective alternative for manual titration, however is recommended only for patient without significant comorbids. Several formulas predicting optimal continuous positive airway pressure (CPAP) for OSA treatment have been developed from Western and Asian studies, with variable parameters used for predictive factors.
Objective: To develop prediction equation for optimal PAP pressure for Malaysians derived from our single center data and compared with current available equations.
Methods:
We retrospectively reviewed 92 patients who undergone sleep titration in Sarawak General Hospital. Published prediction equations (Hofftein, Se cries, Basoglu, Wu, Luo, Choi, Chuang, Liu) were used to calculate the optimal CPAP pressure. Subsequently, we used a stepwise multiple linear regression analysis to develop a predictive equation for optimal CPAP for our patients. 
We evaluated the patients ≧20 years receiving in-lab polysomnography in a tertiary sleep centre between 2010 and 2015. We collected demographic characteristics, sleep efficiency (total sleep time [TST] / time in bed * 100%), oxygen desaturation index (ODI, hourly average number of desaturation episodes) in TST, and hypertension. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) to evaluate the effect of potential risk factors on hypertension by using univariate and multivariate logistic regression models.
Results: A total, 5407 patients (4124 men and 1283 women) were recruited. Mean age were 46.4 AE 14.0 years. The majority of patients (73.6%) were overweight and obese. Sleep efficiency among the study patients were 78.1 AE 15.8%. The mean value of ODI were 22.1 AE 24.5. After adjustment for potential covariates, men, older age, higher BMI, less sleep efficiency, and more ODI in TST were independent risk factors of hypertension.
Conclusion:
Less sleep efficiency and more ODI in TST were associated with development of hypertension. Clinicians should educate and improve sleep efficiency and decrease nocturnal desaturation in terms of primary prevention for hypertension.
